Back to GetFilings.com



UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 10-Q

Quarterly report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
For the quarterly period ended October 31, 2004
or
   
Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
For the transition period from   to  

Commission File Number 1- 4311

PALL CORPORATION
(Exact name of registrant as specified in its charter)

New York
 
11-1541330
(State or other jurisdiction of
incorporation or organization)
 
(I.R.S. Employer
Identification No.)

2200 Northern Boulevard, East Hills, NY
 
11548
(Address of principal executive offices)
 
(Zip Code)

(516) 484-5400
(Registrant’s telephone number, including area code)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrant was required to file such reports), and (2) has been subject to such filing requirement for the past 90 days. Yes No

Indicate by check mark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Exchange Act). Yes No

On December 6, 2004, there were 123,999,373 outstanding shares of the registrant’s common stock, $.10 par value per share.


Back to Contents

Table of Contents

Page No.

PART I. FINANCIAL INFORMATION
   
Item 1. Financial Statements (Unaudited)
       
    Condensed Consolidated Balance Sheets at October 31, 2004 and July 31, 2004.
       
Condensed Consolidated Statements of Earnings for the three months ended October 31, 2004 and October 31, 2003.
       
Condensed Consolidated Statements of Cash Flows for the three months ended October 31, 2004 and October 31, 2003.
       
Notes to Condensed Consolidated Financial Statements.
   
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.
   
Item 3. Quantitative and Qualitative Disclosures About Market Risk.
   
Item 4. Controls and Procedures.
   
PART II. OTHER INFORMATION
   
Item 1. Legal Proceedings.
   
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.
   
Item 6. Exhibits.
   
SIGNATURES
     

2


Back to Contents

PART I. FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS

PALL CORPORATION AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands, except per share data)
(Unaudited)

 
Oct. 31, 2004
July 31, 2004
 




ASSETS
             
Current assets:              
Cash and cash equivalents
  $ 208,388   $ 207,277  
Accounts receivable, net
    440,382     468,905  
Inventories
    338,136     302,861  
Other current assets
    91,337     90,772  




Total current assets
    1,078,243     1,069,815  
Property, plant and equipment, net     604,670     600,383  
Goodwill, net     241,428     239,660  
Intangible assets, net     43,768     44,129  
Other non-current assets     192,646     186,396  




Total assets
  $ 2,160,755   $ 2,140,383  




LIABILITIES AND STOCKHOLDERS’ EQUITY
             
Current liabilities:              
Accounts payable and other current liabilities
  $ 331,666   $ 338,392  
Income taxes
    20,771     42,642  
Current portion of long-term debt
    31,656     30,514  
Notes payable to banks
    32,927     28,968  




Total current liabilities     417,020     440,516  
Long-term debt, net of current portion     509,673     488,686  
Deferred taxes and other non-current liabilities     153,851     156,742  




Total liabilities
    1,080,544     1,085,944  




Stockholders’ equity:              
Common stock, par value $.10 per share
    12,796     12,796  
Capital in excess of par value
    116,427     115,489  
Retained earnings
    993,196     984,117  
Treasury stock, at cost
    (111,388 )   (92,047 )
Stock option loans
    (1,976 )   (2,308 )
Accumulated other comprehensive income (loss):
             
Foreign currency translation
    109,116     77,585  
Minimum pension liability
    (37,559 )   (37,559 )
Unrealized investment losses
    (79 )   (3,275 )
Unrealized losses on derivatives
    (322 )   (359 )




      71,156     36,392  




Total stockholders’ equity     1,080,211     1,054,439  




Total liabilities and stockholders’ equity   $ 2,160,755   $ 2,140,383  




See accompanying notes to condensed consolidated financial statements.

3


Back to Contents

PALL CORPORATION AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF EARNINGS
(In thousands, except per share data)
(Unaudited)

      Three Months Ended    
   




   
 
Oct. 31, 2004
Oct. 31, 2003
   




Net sales   $ 414,732   $ 374,286    
Cost of sales     214,860     194,221    




Gross profit     199,872     180,065    
Selling, general and administrative expenses     145,680     131,907    
Research and development     13,713     13,708    
Restructuring and other charges, net     5,523     (3,703 )  
Interest expense, net     5,707     5,152    




Earnings before income taxes     29,249     33,001    
Income taxes     7,550     8,333    




Net earnings   $ 21,699   $ 24,668    




Earnings per share:              
Basic
 
  $ 0.17   $ 0.20    
Diluted
  $ 0.17   $ 0.19    
                 
Dividends declared per share   $ 0.09   $ 0.09    
Average shares outstanding:                
Basic
 
    124,172     125,436    
Diluted
    125,009     126,507    
                 

See accompanying notes to condensed consolidated financial statements.

4


Back to Contents

PALL CORPORATION AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands)
(Unaudited)

 
Three Months Ended
 
   




   
 
Oct. 31, 2004
Oct. 31, 2003
 




                 
Operating activities:                
Net earnings   $ 21,699   $ 24,668    
Adjustments to reconcile net earnings to net cash provided by operating activities:
               
Restructuring and other charges, net
    5,523     (3,703 )  
Depreciation and amortization of long lived assets
    22,138     21,557    
Other
    1,205     (3,906 )  
Changes in operating assets and liabilities, net of effects of acquisitions and dispositions
    (27,883 )   (5,683 )  




Net cash provided by operating activities     22,682     32,933    




Investing activities:                
Acquisitions of businesses, net of cash acquired     (1,170 )   (679 )  
Dispositions of businesses     1,734        
Advances to and investments in strategic alliances     340     (745 )  
Proceeds from sale of strategic investments     915        
Capital expenditures     (17,546 )   (10,521 )  
Disposals of fixed assets     1,376     524    
Proceeds from sale of retirement benefit assets     10,649     8,785    
Purchases of retirement benefit assets     (10,613 )   (8,665 )  
Other     (1,087 )   (766 )  




Net cash used by investing activities     (15,402 )   (12,067 )  




Financing activities:                
Notes payable     2,669     (3,941 )  
Long-term borrowings     117,300     13,237    
Repayments of long-term debt     (104,313 )   (22,394 )  
Net proceeds from stock plans     10,429     10,073    
Purchase of treasury stock     (29,998 )      
Dividends paid     (11,162 )   (11,210 )  




Net cash used by financing activities     (15,075 )   (14,235 )  




Cash flow for period     (7,795 )   6,631    
Cash and cash equivalents at beginning of year     207,277     149,753    
Effect of exchange rate changes on cash     8,906     4,697    




Cash and cash equivalents at end of period   $ 208,388   $ 161,081    




Supplemental disclosures:              
Interest paid
  $ 11,952   $ 5,079    
Income taxes paid (net of refunds)
    27,757     15,779    

See accompanying notes to condensed consolidated financial statements.

5


Back to Contents

PALL CORPORATION AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(In thousands, except per share data)
(Unaudited)

NOTE 1 – BASIS OF PRESENTATION

The condensed consolidated financial information included herein is unaudited. However, such information reflects all adjustments of a normal recurring nature which are, in the opinion of management, necessary to present fairly the Company’s consolidated financial position, results of operations and cash flows as of the dates and for the periods presented herein. These condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes set forth in the Company’s Annual Report on Form 10-K for the fiscal year ended July 31, 2004 (“2004 Form 10-K”).

Certain prior year amounts have been reclassified to conform to the current year presentation.

STOCK PLANS

On September 17, 2004, the Board of Directors approved the 2005 Stock Compensation Plan (the “2005 Plan”) providing for the issuance of up to 5,000 shares and amended the 2001 Stock Option Plan for Non-Employee Directors to reduce the total number of shares remaining available for grants made under that plan to 150. The 2005 Plan permits the Company to grant to its employees forms of equity compensation other than stock options (that is, restricted shares, restricted units, performance shares and performance units). The Company’s shareholders approved the 2005 Plan at the annual shareholders’ meeting on November 17, 2004. All other Company stock option plans have been terminated effective November 17, 2004, but options outstanding thereunder will remain in effect in accordance with their terms.

The Company has elected to continue to apply Accounting Principles Board Opinion No. 25, Accounting for Stock Issued to Employees, to account for its stock plans.

The following table illustrates the effect on net earnings and earnings per share if the Company had accounted for its stock based compensation plans using the Black-Scholes option pricing model to determine the fair value of stock based compensation under Statement of Financial Accounting Standard (“SFAS”) No. 123, as amended by SFAS No. 148:

         
      Three Months Ended  
   




 
     Oct. 31, 2004    Oct. 31 2003  
   

 

 
Net earnings, as reported   $ 21,699   $ 24,668  
Pro forma stock compensation expense, net of tax benefit     2,848     2,848  




Pro forma net earnings   $ 18,851   $ 21,820  




               
Earnings per share:              
Basic—as reported   $ .17   $ .20  
Basic—pro forma   $ .15   $ .17  
Diluted—as reported   $ .17   $ .19  
Diluted—pro forma   $ .15   $ .17  

NOTE 2 – RECENTLY ISSUED ACCOUNTING PRONOUNCEMENTS

In November 2004, the Financial Accounting Standards Board (“FASB”) issued SFAS No. 151, Inventory Costs, an amendment of ARB No. 43, Chapter 4 (“SFAS No. 151”). SFAS No. 151 amends guidance in ARB No. 43, Chapter 4, Inventory Pricing, to clarify the accounting for abnormal amounts of idle facility expense, freight handling costs and wasted material requiring that such items be recognized as current-period charges. In addition, SFAS No. 151 requires that the allocation of fixed production overheads to the costs of conversion be based on the normal capacity of the production facilities. SFAS No. 151 will become effective for fiscal years beginning after June 15, 2005. The Company is in the process of assessing the effect of SFAS No. 151.

On October 22, 2004, the American Jobs Creation Act of 2004 (the “Act”) was signed into law. The Act provides for a special one-time tax deduction of 85% of certain foreign earnings that are repatriated, as defined in the Act. On November 15, 2004, the FASB issued a proposed FASB staff position, Accounting and Disclosure Guidance for the Foreign Earnings Repatriation Provision within the American Jobs Creation Act of 2004 (“SFAS 109-b”). SFAS 109-b would allow companies additional time to evaluate the effect of the Act as to whether unrepatriated foreign earnings continue to qualify for the SFAS 109 exception regarding non-recognition of deferred tax liabilities and would require explanatory disclosures from those who need the additional time. Through October 31, 2004, the Company has not provided deferred taxes on the undistributed earnings of foreign subsidiaries since substantially all such earnings were expected to be permanently invested in foreign operations. Whether the Company will ultimately take advantage of this provision depends on a number of factors, including reviewing future Congressional or Treasury Department guidance, before a determination can be made. The range of reasonably possible amounts that are being considered for repatriation due to the aforementioned provision is between zero and $500,000. The related potential range of income tax is between zero and $26,250.

6


Back to Contents

PALL CORPORATION AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (continued)
(In thousands, except per share data)
(Unaudited)

NOTE 3 – BALANCE SHEET DETAILS

The following tables provide details of selected balance sheet items:
               
   
Oct. 31, 2004
July 31, 2004
 
   

 

 
Accounts receivable, net:              
Accounts receivable
  $ 453,256   $ 480,967  
Less: Allowances for doubtful accounts
    12,874     12,062  




  $ 440,382   $ 468,905  




               
Inventories:              
Raw materials and components
  $ 97,458   $ 88,341  
Work-in-process
    49,247     45,747  
Finished goods
    191,431     168,773  




  $ 338,136   $ 302,861  




               
Property, plant and equipment, net:              
Property, plant and equipment
  $ 1,244,999   $ 1,216,447  
Less: Accumulated depreciation and amortization
    640,329     616,064  




  $ 604,670   $ 600,383  




NOTE 4 – GOODWILL AND INTANGIBLE ASSETS

The following table presents goodwill, net of accumulated amortization, allocated by reportable segment in accordance with
SFAS No. 142:
               
   
Oct. 31, 2004
July 31, 2004
   

 

 
               
Medical   $ 28,929   $ 28,433  
BioPharmaceuticals     28,632     28,602  




Life Sciences     57,561     57,035  




General Industrial     155,755     154,753  
Aerospace     6,436     6,127  
Microelectronics     21,676     21,745  




Industrial     183,867     182,625  




    $ 241,428   $ 239,660  




       
The change in the carrying amount of goodwill is primarily attributable to the changes in foreign exchange rates used to translate the goodwill contained in the financial statements of foreign subsidiaries using the rates at each respective balance sheet date. In addition, goodwill has been restated for the Life Sciences segment for July 31, 2004 consistent with the Company’s implementation of an integrated business approach in the first quarter of fiscal 2005. Refer to the Segment Information and Geographies note for a more detailed description.

7


Back to Contents

PALL CORPORATION AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (continued)
(In thousands, except per share data)
(Unaudited)

Intangible assets, net, consist of the following:
               
      Oct. 31, 2004     July 31, 2004  
   




 




 
     
Gross
Accumulated Amortization
Gross
Accumulated
Amortization
 
   

 

 

 

 
Patents and unpatented technology   $ 77,592   $ 37,445   $ 76,724   $ 36,108  
Trademarks     3,653     1,510     3,619     1,432  
Other     5,354     3,876     5,090     3,764  








    $ 86,599   $ 42,831   $ 85,433   $ 41,304  








               
Amortization expense for these intangible assets for the three months ended October 31, 2004 and October 31, 2003 was $1,473 and $2,003, respectively. Amortization expense is estimated to be approximately $4,449 for the remainder of fiscal 2005 and $5,900 in 2006, $5,800 in 2007, $4,900 in 2008, $4,500 in 2009 and $4,500 in 2010.

NOTE 5 – OTHER NON-CURRENT ASSETS

At October 31, 2004, the Company owned 6,175 shares of the common stock of V.I. Technologies, Inc. (“VITEX”). At July 31, 2004, the Company’s cost basis in this investment was $1.27 per share. The market price of VITEX shares was trading between $0.81 and $1.12 per share during the time period from July 31, 2004 to October 31, 2004. The stock closed at $.80 per share on October 31, 2004. During November 2004, the stock price fluctuated between $0.58 and $0.83. Company management believes that this volatility is related to the following events: (1) VITEX’s amended merger agreement with Panacos Pharmaceuticals, which was announced on November 8, 2004, (2) the notification to VITEX on November 10, 2004, from the NASDAQ Stock Market, informing them that VITEX did not comply with the $10 million minimum stockholders’ equity requirement for continued listing, and (3) VITEX’s announcement on November 23, 2004, of the temporary suspension of enrollment in its Phase III surgical study for their INACTINE ™ pathogen reduction system, following identification of an immune response in one patient in the study. Based on these recent events, and the fact that VITEX’s share price has not approached the Company’s cost basis of $1.27 per share during the past six months, Management has concluded that its investment in VITEX is other-than-temporarily impaired. As such, the Company’s investment in VITEX has been recorded at the October 31, 2004 fair market value of $0.80 per share, or $4,940 in the accompanying condensed consolidated balance sheet and the Company recorded an impairment charge of $2,875 in the quarter. Refer to the Restructuring and Other Charges, Net note. As of July 31, 2004, an unrealized loss of $2,813 related to this investment was recorded in the other comprehensive income/(loss) component of stockholders equity.

NOTE 6 – PRODUCT WARRANTY

The Company warrants its products against defect in design, materials and workmanship over various time periods. Warranty costs are recorded based upon experience. The warranty accrual as of October 31, 2004 and July 31, 2004 is immaterial to the consolidated financial position of the Company and the change in the accrual for the current quarter of fiscal 2005 is immaterial to the Company's consolidated results of operations, cash flows or financial position.

NOTE 7 – TREASURY STOCK

On October 17, 2003, the Company’s Board of Directors (“the Board”) authorized the expenditure of up to $200,000 to repurchase shares of the Company’s common stock. On October 14, 2004, the Board authorized the additional expenditure of up to another $200,000 for the repurchase of the Company’s common stock. The Company’s shares may be purchased over time, as market and business conditions warrant. There is no time restriction on this authorization. During the first quarter of fiscal 2005, the Company purchased 1,228 shares in open-market transactions at an aggregate cost of $29,998 with an average price per share of $24.43. Therefore, $295,002 remains to be expended under the current stock repurchase programs. Repurchased shares are held in treasury for use in connection with the Company’s stock plans and for general corporate purposes.

During the three months ended October 31, 2004, 453 shares were issued under the Company’s stock plans. At October 31, 2004, the Company held 4,712 treasury shares.

8


Back to Contents

PALL CORPORATION AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (continued)
(In thousands, except per share data)
(Unaudited)

NOTE 8 – LONG-TERM DEBT

On August 24, 2004, the Company entered into a $300,000 unsecured senior revolving credit facility with a syndicate of banks, which expires on August 24, 2009. Simultaneously, the Company borrowed $125,000 under this facility principally to repay (1) $71,200 ($54,000 outstanding as of July 31, 2004) of borrowings under its existing $200,000 unsecured senior revolving credit facility entered into on August 29, 2000, (2) the $50,000 balance due on its $100,000 bank loan entered into on October 18, 2002, which otherwise was to mature on October 18, 2007 and (3) various fees associated with the new facility. Both the $200,000 revolving credit facility and the $100,000 term loan were terminated upon the execution of the new revolving credit facility.

Borrowings under the new facility bear interest at either a variable rate based upon LIBOR or at the prime rate of the Administrative Agent. The new facility contains customary affirmative and negative covenants, financial covenants, representations and warranties and events of defaults. The financial covenants are as follows:

i. Minimum interest coverage ratio: The Ratio of Earnings Before Net Interest, Taxes, Depreciation, Amortization and the Non-Cash Portion of Non-Recurring Charges and Income (“EBITDA”) to Net Interest Expense shall not be less than 5 to 1 for the last four consecutive fiscal quarters.
   
ii. Maximum funded debt ratio: The Ratio of Consolidated Funded Debt to EBITDA shall not exceed 3 to 1.
   
The Company was in compliance with all covenants of its various debt agreements.

NOTE 9 – CONTINGENCIES AND COMMITMENTS

In connection with the previously reported lawsuit brought against a Company subsidiary, Gelman Sciences Inc. (“Gelman”) relating to groundwater contamination, in February 2004, the Court instructed Gelman to submit its Final Feasibility Study describing how it intends to address an area of groundwater contamination not addressed by the previously approved plan. Gelman has submitted its Feasibility Study as instructed. The State also submitted its plan for remediating this area of contamination. The State’s plan requires extensive and costly actions not contemplated by Gelman’s plan and in the opinion of Company management is not an efficient and expeditious manner to conduct the remediation. Management believes Gelman’s plan is the best course of action and the liabilities in the October 31, 2004 condensed consolidated balance sheet are based upon the estimated costs to complete Gelman’s plan. Management estimates the State’s plan, as management currently understands it, could increase the cost of the remediation by as much as $28,000 over Gelman’s plan. On September 8, 2004, the Court advised the parties that it would issue an order modifying its previous Remediation Enforcement Order by November 8, 2004 to address the recently discovered contamination. Although the Court indicated that the modified order would be issued by November 8, 2004, the matter remains under the Court’s consideration as of December 10, 2004, the date of this report. The Company’s balance sheet at October 31, 2004 includes liabilities for environmental matters of $28,223, which relates mainly to the aforementioned remediation. In the opinion of management, the Company is in substantial compliance with applicable environmental laws and its current accruals for environmental remediation are adequate. However, because regulatory standards under environmental laws are becoming increasingly stringent, there can be no assurance that future developments, additional information and experience gained will not cause the Company to incur material environmental liabilities or costs beyond those accrued in its condensed consolidated financial statements.

9


Back to Contents

PALL CORPORATION AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (continued)
(In thousands, except per share data)
(Unaudited)

NOTE 10 – RESTRUCTURING AND OTHER CHARGES, NET

The following tables summarize the restructuring related items and other charges/(income) recorded for the three months ended October 31, 2004 and October 31, 2003:
     
 
Three Months Ended
Oct. 31, 2004
   
Restructuring
 
 
Other
Charges/ (Income)
 
 
Total
 

 

 

 

 
Impairment of investments (a)   $   $ 2,875   $ 2,875  
Severance (b)     2,665         2,665  
Other exit costs (b)     485         485  
Gain on sale of assets (b)     (387 )       (387 )
Other         (115 )   (115 )






    $ 2,763   $ 2,760   $ 5,523  






                     
Cash   $ 2,763   $ 95   $ 2,858  
Non-cash         2,665     2,665  






    $ 2,763   $ 2,760   $ 5,523  






Three Months Ended
Oct. 31, 2003
                   

                   
Severance (b)   $ 1,570   $